Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03712241 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT03712241 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 15 participants.
The verdict
NCT03712241, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is to compare the PK parameters of multiple doses and applications of K-285 with a single dose of indomethacin capsule.
Interventions
- DRUG Indomethacin
- DRUG K-285
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2019-01-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03712241
The ClinicalTrials.gov registry entry for NCT03712241 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin is the first listed.
NCT03712241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03712241 about?
NCT03712241 is a clinical study titled "Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults". This study is to compare the PK parameters of multiple doses and applications of K-285 with a single dose of indomethacin capsule.
What is the current status of trial NCT03712241?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2018-10-04. Estimated completion is 2019-01-06.
What interventions are being tested in trial NCT03712241?
The interventions under investigation include: Indomethacin (DRUG), K-285 (DRUG).
Who is sponsoring clinical trial NCT03712241?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.